WallStreetZenWallStreetZen

NASDAQ: RPHM
Reneo Pharmaceuticals Inc Stock

$5.90-0.14 (-2.32%)
Updated Mar 27, 2023
RPHM Price
$5.90
Fair Value Price
N/A
Market Cap
$145.73M
52 Week Low
$1.79
52 Week High
$6.71
P/E
-2.78x
P/B
1.46x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$51.96M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.08
Operating Cash Flow
-$47M
Beta
0.83
Next Earnings
May 8, 2023
Ex-Dividend
N/A
Next Dividend
N/A

RPHM Overview

Reneo Pharmaceuticals Incorporated develops therapies for patients with rare genetic mitochondrial diseases. REN001 is a selective peroxisome proliferator-activated receptor delta agonist in (1) Phase IIb clinical trials in patients with primary mitochondrial myopathies, and (2) Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals was incorporated in 2014 and is headquartered in San Diego, CA.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RPHM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RPHM is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RPHM is good value based on its book value relative to its share price (1.46x), compared to the US Biotechnology industry average (4.86x)
P/B vs Industry Valuation
RPHM is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more RPHM due diligence checks available for Premium users.

Be the first to know about important RPHM news, forecast changes, insider trades & much more!

RPHM News

Valuation

RPHM fair value

Fair Value of RPHM stock based on Discounted Cash Flow (DCF)
Price
$5.90
Fair Value
$8.40
Undervalued by
29.73%
RPHM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

RPHM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.78x
Industry
18.55x
Market
21.44x

RPHM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.46x
Industry
4.86x
RPHM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RPHM's financial health

Profit margin

Revenue
$0.0
Net Income
-$13.6M
Profit Margin
0%
RPHM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$108.2M
Liabilities
$8.2M
Debt to equity
0.08
RPHM's short-term assets ($106.35M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RPHM's short-term assets ($106.35M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RPHM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$15.6M
Investing
-$26.9M
Financing
$325.0k
RPHM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

RPHM vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
RPHM$145.73M-2.32%-2.78x1.46x
NKTR$145.71M+7.24%-0.39x0.40x
IMMP$145.96M-6.21%-5.72x2.76x
GTBP$145.00M-7.20%-0.57x9.09x
GTHX$144.12M+8.56%-0.83x2.10x

Reneo Pharmaceuticals Stock FAQ

What is Reneo Pharmaceuticals's quote symbol?

NASDAQ: RPHM) Reneo Pharmaceuticals trades on the NASDAQ under the ticker symbol RPHM. Reneo Pharmaceuticals stock quotes can also be displayed as NASDAQ: RPHM.

If you're new to stock investing, here's how to buy Reneo Pharmaceuticals stock.

What is the 52 week high and low for Reneo Pharmaceuticals (NASDAQ: RPHM)?

(NASDAQ: RPHM) Reneo Pharmaceuticals's 52-week high was $6.71, and its 52-week low was $1.79. It is currently -12.07% from its 52-week high and 229.61% from its 52-week low.

How much is Reneo Pharmaceuticals stock worth today?

(NASDAQ: RPHM) Reneo Pharmaceuticals currently has 24,699,553 outstanding shares. With Reneo Pharmaceuticals stock trading at $5.90 per share, the total value of Reneo Pharmaceuticals stock (market capitalization) is $145.73M.

Reneo Pharmaceuticals stock was originally listed at a price of $13.89 in Apr 9, 2021. If you had invested in Reneo Pharmaceuticals stock at $13.89, your return over the last 1 years would have been -57.52%, for an annualized return of -57.52% (not including any dividends or dividend reinvestments).

How much is Reneo Pharmaceuticals's stock price per share?

(NASDAQ: RPHM) Reneo Pharmaceuticals stock price per share is $5.90 today (as of Mar 27, 2023).

What is Reneo Pharmaceuticals's Market Cap?

(NASDAQ: RPHM) Reneo Pharmaceuticals's market cap is $145.73M, as of Mar 29, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Reneo Pharmaceuticals's market cap is calculated by multiplying RPHM's current stock price of $5.90 by RPHM's total outstanding shares of 24,699,553.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.